Clinical Evaluation in Real Life of TLC-NOSF Dressings in the Local Treatment of Chronic Wounds (DFU and VLU)

Inclusion Criteria: * Adult outpatient having signed informed consent * Patient with a venous leg ulcer (VLU) Or with a diabetic foot ulcer (DFU) * Prescription of one of the 3 dressings: UrgoStart Plus® Border, UrgoStart Plus® pad or UrgoStart Interface® * Patient can be followed over 12 weeks by the investigator, according to his/her practices * Patient able to participate in the study and complete a self-questionnaire without difficulty Exclusion Criteria: * Hemorrhagic wound * Cancerous wound * Fistulous wound revealing a deep abscess * Presence of dry necrosis partially or completely covering the wound bed * Infected wound * Osteitis * Critical or acute ischemia * Patient for whom a surgical procedure related to the treated wound is scheduled within 12 weeks following the inclusion visit * Patient with known sensitivity to one of the studied dressings components * Pregnant or breastfeeding patient * Patient under the protection of justice or under guardianship or deprived of liberty